Abstract
IgG4-related disease sometimes involves regional and/or systemic lymph nodes, and often clinically and/or histologically mimics multicentric Castleman's disease or malignant lymphoma. In this study, we examined clinical and pathologic findings of nine patients with systemic IgG4-related lymphadenopathy. None of these cases were associated with human herpes virus-8 or human immunodeficiency virus infection, and there was no T-cell receptor or immunoglobulin gene rearrangement. Histologically, systemic IgG4-related lymphadenopathy was classified into two types by the infiltration pattern of IgG4-positive cells: interfollicular plasmacytosis type and intra-germinal center plasmacytosis type. The interfollicular plasmacytosis type showed either Castleman's disease-like features or atypical lymphoplasmacytic and immunoblastic proliferation-like features. By contrast, the intra-germinal center plasmacytosis type showed marked follicular hyperplasia, and infiltration of IgG4-positive cells mainly into the germinal centers, and some cases exhibited features of progressively transformed germinal centers. Interestingly, eight of our nine (89%) cases showed eosinophil infiltration in the affected lymph nodes, and examined patients showed high elevation of serum IgE. Laboratory examinations revealed elevation of serum IgG4 and soluble interleukin-2 receptors. However, the levels of interleukin-6, C-reactive protein, and lactate dehydrogenase were within normal limits or only slightly elevated in almost all patients. One patient showed a high interleukin-6 level whereas C-reactive protein was within the normal limit. Autoantibodies were examined in five patients and detected in four. Compared with the previously reported cases of multicentric Castleman's disease, our patients with systemic IgG4-related lymphadenopathy were significantly older and had significantly lower C-reactive protein and interleukin-6 levels. In conclusion, in our systemic IgG4-related lymphadenopathy showed pathologic features only partially overlapping those of multicentric Castleman's disease, and serum data (especially C-reactive protein and interleukin-6) are useful for differentiating the two. Our findings of eosinophil infiltration in the affected tissue and elevation of serum IgE may suggest an allergic mechanism in the pathogenesis of systemic IgG4-related lymphadenopathy.
Similar content being viewed by others
Main
Recently, autoimmune pancreatitis and its related disorders, such as sclerosing cholangitis, sclerosing sialadenitis (Küttner's tumor), retroperitoneal fibrosis, and Mikulicz's disease have been shown to share IgG4-related abnormalities. Such abnormalities include an elevated serum IgG4 level and numerous IgG4-positive plasma cells infiltrating the affected tissue, and these disorders are classified as IgG4-related diseases.1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
Castleman's disease is a rather rare atypical lymphoproliferative disorder12 classified according to the histopathologic findings of the affected lymph nodes as plasma cell type, hyaline-vascular type or a mixed-type variant of the two.13, 14 Patients with the plasma cell or the mixed-type variant frequently have systemic manifestations (so-called multicentric Castleman's disease), such as low-grade fever, fatigue, loss of appetite, and weight loss. Abnormal laboratory findings include anemia, hypoalbuminemia, hypocholesterolemia, hypergammaglobulinemia, increased C-reactive protein, and interleukin-6.13, 14, 15, 16 These symptoms are closely related to high interleukin-6 levels, suggesting a cytokine disease. Idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia is considered identical to multicentric Castleman's disease in Western countries.17, 18 Idiopathic plasmacytic lymphadenopathy and multicentric Castleman's disease show similar clinicopathology. However, idiopathic plasmacytic lymphadenopathy has a significantly better 5-year survival rate than multicentric Castleman's disease.17, 18 Multicentric Castleman's disease exhibits an aggressive and usually fatal disease course associated with infectious complications and risk of malignant tumors; one-third of such patients develop Kaposi sarcoma or B-cell lymphoma.17, 18
IgG4-related disease sometimes involves regional and/or systemic lymph nodes,3, 4, 11 and is often clinically and/or histologically suspected to be multicentric Castleman's disease and/or malignant lymphoma.5, 6, 11 However, systemic IgG4-related lymphadenopathy is either not mentioned or only briefly alluded to in previous reports.3, 11
In this study, we examined systemic IgG4-related lymphadenopathy in detail, and its differences from multicentric Castleman's disease, with specific reference to clinical and pathologic findings.
Materials and methods
Patients and Materials
Nine Japanese patients with systemic IgG4-related lymphadenopathy were clinicopathologically examined. All cases were retrieved from the surgical pathology consultation files of the Department of Pathology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University in Okayama, Japan. The preliminary diagnostic criteria consisted of an elevated serum IgG4 value (>135 mg/dl) and infiltration of IgG4-positive cells in the affected lymph nodes (IgG4/IgG-positive cell ratio >40%). These diagnostic criteria were suggested by previous reports.6, 11
Clinical information was obtained from the patient records, referring pathologists, or clinicians. All data and samples from patients were collected with their informed consent.
Histological Examination and Immunohistochemistry
Surgically biopsied lymph node specimens were fixed in 10% formaldehyde and embedded in paraffin. Serial sections (4 μm) were cut from each paraffin-embedded tissue block, and several sections were stained with hematoxylin and eosin.
Immunohistochemistry was performed on paraffin sections using an automated Benchmark XT slide stainer (Ventana Medical Systems Inc., Tucson, AZ, USA). Tissue sections underwent standardized heating pretreatment for antigen retrieval prior to the immunohistochemical procedure. Primary antibodies used were: CD20 (L26; 1:200; Novocastra, Newcastle, UK), CD3 epsilon (PS-1; 1:50; Novocastra), CD5 (4C7; 1:100; Novocastra), CD10 (56C6; 1:50; Novocastra), CD21 (1F8; 1:20; Dako, Carpinteria, CA, USA), CD138 (MI15; 1:100; Dako), Bcl-2 (3.1; 1:200; Novocastra), IgG (Polyclonal; 1:10 000; Dako), IgG4 (HP6025; 1:1000; The Binding Site, Birmingham, UK), Kappa (NCL-KAP; 1:100; Novocastra), Lambda (NCL-LAM; 1:200; Novocastra), and human herpes virus type-8 (137B1; 1:50; Novocastra).
The number of IgG4- or IgG-positive cells was estimated at the areas with the highest density of positive cells. Five different high-power fields (HPF: × 10 eyepiece and × 40 lens) in each section were counted, and the average number of positive cells per HPF was calculated.
Polymerase Chain Reaction for Detecting Immunoglobulin Heavy Chain Gene and T-Cell Receptor Gene Rearrangements
Polymerase chain reaction was used in the analysis of the immunoglobulin heavy chain gene and T-cell receptor gamma gene rearrangement. Polymerase chain reaction was performed according to standard procedures as described previously.19, 20, 21, 22
The primers used for immunoglobulin heavy chain gene amplification were as follows:19, 20, 21 5′-TGG[A/G] TCCG[C/A] CAG [G/C] C [T/C][T/C] C [A/C/G/T] GG-3′ as the upstream consensus V region primer; 5′-TGAGGAGACGGTGACC-3′ as the consensus J region primer; and 5′-GTGACCAGGGT [A/C/G/T] CCTTGGCCCCAG-3′ as the consensus J region primer.
The primers used for T-cell receptor gamma gene amplification were as follows.22
for tube A:
VgIf: 5′-GGAAGGCCCCACAGCRTCTT-3′
Vg10: 5′-AGCATGGGTAAGACAAGCAA-3′
Jg1.1/2.1: 3′-CGAGTAYCATTGAAGCGGACCATT-5′
Jg1.3/2.3: 3′-GAGAAACCGTCACCTTGTTGTG-5′
for tube B:
Vg9: 5′-CGGCACTGTCAGAAAGGAATC-3′
Vg11: 5′-CTTCCACTTCCACTTTGAAA-3′
Jg1.1/2.1: 3′-CGAGTAYCATTGAAGCGGACCATT-5′
Jg1.3/2.3: 3′-GAGAAACCGTCACCTTGTTGTG-5′
Statistical Analysis
All statistical analyses were carried out using the Mann–Whitney U-test with SPSS software (version 14.0; SPSS Inc., Chicago, IL, USA). Values of P<0.01 were considered statistically significant.
Results
Clinical Findings
The clinical findings are summarized in Tables 1 and 2. There were seven men and two women with a median age of 72.0 years (range, 45–82 years). All patients showed systemic lymphadenopathy, and clinically, and/or histologically suspected multicentric Castleman's disease, and/or malignant lymphoma. The size of the lymph nodes ranged from 1 to 2 cm in diameter, with an average of 1.7 cm. Analysis of the patient lifestyles did not suggest any risk factors for human immunodeficiency virus infection, and anti-human immunodeficiency virus-1 antibody was negative in the seven patients examined. Various autoantibodies were detected in four of five patients examined (Table 1). Hypergammaglobulinemia was detected in all patients, although serum IgM and IgA was normal in almost all patients. However, the serum IgE value was significantly elevated in the examined patients. The serum IgG4 level was also significantly elevated (average=818.44 mg/dl; s.d.=502.94) in all patients. C-reactive protein was normal or only slightly elevated (average=0.29 mg/dl; s.d.=0.25). Interleukin-6 was normal or only slightly elevated (average=8.45 pg/ml; s.d.=11.61), but one patient showed a high interleukin-6 level whereas C-reactive protein was within the normal limit. Lactate dehydrogenase was normal or only slightly elevated (average=197.22 IU/l; s.d.=51.29). In contrast, soluble interleukin-2 receptor was significantly elevated (average=1875.78 U/ml; s.d.=835.87). Hemoglobin, albumin and total cholesterol were normal in almost all patients. Compared with previous reports of multicentric Castleman's disease,16 our patients with systemic IgG4-related lymphadenopathy showed more advanced age distribution, no significant elevation of C-reactive protein or interleukin-6 levels, no anemia, no hypoalbuminemia, and no hypocholesterolemia. These differences between the groups were statistically significant (Table 3).
Pathological and Immunohistological Findings of the Lymph Node
Histologically and immunohistologically, we classified the cases into two types by the infiltration pattern of IgG4-positive cells; interfollicular plasmacytosis type and intra-germinal center plasmacytosis type (Table 4) .
The IgG4/IgG-positive cells ratio ranged from 44.7 to 72.7%, with an average of 57.6%.
Interfollicular Plasmacytosis Type
The lymph nodes of patient no. 1, 2, 3, 4, 5, and 6 were of interfollicular plasmacytosis type. On low-power field, the lymph nodes demonstrated many germinal centers, usually normal to atrophic with a distinct mantle zone and expansion of the interfollicular area. The interfollicular area showed a moderate to marked increase in vascularity, and heavy infiltration with mature plasma cells, plasmacytoid cells, small lymphocytes, and eosinophils. The follicular dendritic cell networks showed a normal or reactive pattern in all cases. Histologically, the lymph nodes of patients no. 1, 3, and 4 showed Castleman's disease-like features (Figure 1). In contrast, the lymph nodes of patients no.2, 5, and 6 showed atypical lymphoplasmacytic and immunoblastic proliferation23, 24 -like features (Figure 2) —ie, the lymph nodes had germinal centers that were usually atrophic to normal, and prominent lymphoplasmacytic infiltration with various numbers of immunoblasts in the interfollicular area. Compared with the histology of the Castleman disease-like features, the histology of atypical lymphoplasmacytic and immunoblastic proliferation-like features was characterized by decreased lymphoid follicles, atrophic germinal centers, a marked increase in vascularity, and more distinct immunoblasts.
Five of these six cases showed eosinophil infiltration in the interfollicular area. In terms of immunohistochemistry, IgG4-positive cells infiltrated the interfollicular areas, and the IgG4/IgG-positive cell ratio ranged from 44.7 to 72.7%, with an average of 56.7%. Three of six patients had exocrine organ lesions, and one patient (patient no. 6) had a skin lesion (not examined histologically).
There were no human herpes virus type-8-positive cells, no immunoglobulin light-chain restriction, and no immunoglobulin heavy chain gene rearrangement in any cases. In addition, there was no T-cell receptor gamma gene rearrangement in the atypical lymphoplasmacytic and immunoblastic proliferation-like cases (patient nos. 2, 5, and 6).
Intra-Germinal Center Plasmacytosis Type
The lymph nodes of patient nos. 7, 8, and 9 were the intra-germinal center plasmacytosis type. On low-power field, the lymph nodes demonstrated numerous lymphoid follicles with hyperplastic germinal centers and a distinct mantle zone, and no expansion of the interfollicular area. The interfollicular area showed numerous eosinophils and a small number of mature plasma cells and plasmacytoid cells. In contrast, the intra-germinal center showed extensive infiltration with mature plasma cells and plasmacytoid cells. Follicular dendritic cell networks showed a normal or reactive pattern in all cases. Two cases (patient nos. 8 and 9) showed a focal progressively transformed germinal center (Figure 3).
Immunohistochemically, IgG4-positive cells mainly infiltrated the intra-germinal center, and the percentage of IgG4/IgG-positive cells ratio ranged from 56.5 to 63.0%, with an average of 59.4%.
Two of the three patients had exocrine organ lesions. In addition, two patients (nos. 8 and 9) had skin lesions. Histologically, the skin lesions showed lymphoplasmacytic infiltration with abundant IgG4-positive cells and eosinophils (Figure 4).
There were no human herpes virus type-8-positive cells, and no immunoglobulin light-chain restriction or immunoglobulin heavy chain gene rearrangement in any cases.
Discussion
IgG4-related disease is a recently recognized syndrome characterized by mass-forming lesions in mainly exocrine tissue due to lymphoplasmacytic infiltrates and sclerosis, increased serum IgG4 level, and IgG4-positive plasma cells in the affected tissues.1, 2, 3, 4, 5, 6, 7, 8, 9, 10 Clinical manifestations are apparent in the pancreas, bile duct, gallbladder, lacrimal gland, salivary gland, retroperitoneum, kidney, lung, and prostate, in which tissue fibrosis is pathologically induced.1, 2, 3, 4, 5, 6, 7, 8, 9, 10 Recently, many cases have been reported in Western countries, as well as in Japan.3 However, the precise pathogenesis and pathophysiology of IgG4-related disease remain unclear. As patients presenting with prominent fibrosis are frequently suspected of having malignant tumors, IgG4-related disease should be considered in the differential diagnosis to avoid unnecessary surgery.1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Recent studies have reported that IgG4-related disease sometimes involves the systemic lymph nodes but clinicopathological characteristics have not been well documented yet.3, 4, 11 In this study, we sought to clarify the clinicopathologic features of systemic IgG4-related lymphadenopathy. The clinical findings of systemic lymphadenopathy and hypergammaglobulinemia, which are characteristic of systemic IgG4-related lymphadenopathy, are also highly reminiscent of multicentric Castleman's disease.15, 16, 17, 18 However, none of our patients had anemia, hypoalbuminemia, or hypocholesterolemia, and elevated interleukin-6 and C-reactive protein were the exceptions. These findings are quite different from those of multicentric Castleman's disease.15, 16, 17, 18
Interleukin-6 is a multifunction cytokine that has various biological activities in target cells and regulates immune responses, acute phase reactions, hematopoiesis, and bone metabolism.25 Dysregulated overproduction of interleukin-6 is found in autoimmune diseases, such as rheumatoid arthritis, multicentric Castleman's disease, and Crohn's disease.16, 17, 18, 26, 27 C-reactive protein is a pentamer of 23-kd subunits that is synthesized and secreted by hepatocytes upon stimulation by a variety of inflammatory cytokines, including tumor necrosis factor-α, interleukin-1, and especially interleukin-6. Therefore, interleukin-6 is closely related to the production of C-reactive protein.25, 26, 27, 28, 29 Accordingly, interleukin-6 and C-reactive protein may become considerably important as differential diagnostic markers between systemic IgG4-related lymphadenopathy and multicentric Castleman's disease. Masaki et al6 have reported that IgG4-related disease is not associated with an elevated serum interleukin-6 level, and cited measurement of serum interleukin-6 as an important tool of differential diagnosis. In our present series, two patients (nos. 2 and 4) showed slight, and one patient (no. 6) showed high elevation of serum interleukin-6, but their C-reactive protein levels were not as highly elevated as in multicentric Castleman's disease. Our patients using steroids showed a good response, and the histological findings of patient nos. 2 and 6 showed no similarities to those of Castleman's disease. The reference value of interleukin-6 is generically <4.0 pg/ml. However, Yokayama30 has reported that the interleukin-6 value was over 25 pg/ml in 7% of the healthy subjects. Therefore, interleukin-6 values might vary widely among individuals.
Our patients with systemic IgG4-related lymphadenopathy all showed hypergammaglobulinemia, but serum IgM and IgA was normal in almost all patients. In contrast, multicentric Castleman's disease is characterized by increased serum IgG, IgM, and IgA levels,16 which are caused by the increase in serum interleukin-6.5 In this series, most patients showed cervical, hilar, mediastinal, and para-aortic lymph node swelling, and the lymph nodes were generally not very large (up to 2 cm). These findings were consistent with previous reports of IgG4-related lymphadenopathy.3, 4, 11
Histologically, we could classify the cases into two types based on the infiltration pattern of IgG4-positive cells: interfollicular plasmacytosis type and intra-germinal center plasmacytosis type. Morphologically, the interfollicular plasmacytosis type was characterized by expansion of the interfollicular area, moderate to marked increase in vascularity, and infiltration of IgG4-positive cells mainly in the interfollicular area. Five out of six cases showed eosinophil infiltration in the interfollicular area. These cases demonstrated Castleman disease-like features (patient nos. 1, 3, and 4) or atypical lymphoplasmacytic and immunoblastic proliferation-like features (patient nos. 2, 5, and 6). Koo et al23 reported that atypical lymphoplasmacytic and immunoblastic proliferation is unusual in cases of lymph node lesion associated with various autoimmune diseases, including rheumatoid arthritis. Histopathologically, the lesion is characterized by prominent lymphoplasmacytic infiltration with various number of immunoblasts.23, 24 In this series, three patients showed this pattern, but there was no evidence of rheumatoid arthritis. In addition, there was abundant IgG4-positive cells infiltration in the lesion and the serum IgG4 value was elevated. These findings are consistent with IgG4-related disease. These results suggested that some IgG4-related lymphadenopathy might be confused with multicentric Castleman's disease or atypical lymphoplasmacytic and immunoblastic proliferation. In the case of systemic IgG4-related lymphadenopathy of atypical lymphoplasmacytic and immunoblastic proliferation type, the histology can be confused with that of malignant lymphoma, especially angioimmunoblastic T-cell lymphoma. However, the former has no clear cells, no CD10-positive T-cells, no extrafollicular follicular dendritic cell proliferation, and no T-cell receptor gamma gene rearrangement.
By contrast, the intra-germinal center plasmacytosis type shows marked follicular hyperplasia, a mild increase in vascularity, and IgG4-positive cells mainly infiltrating the germinal centers. In our study, the two patients with this type showed progressively transformed germinal center. The germinal centers are known to be a major site for B-cell selection. In the germinal centers, B cells perform numerous somatic hypermutations and heavy-chain class-switches and only a portion of them are selected through the cooperation of T cells and follicular dendritic cells. The selected B cells exit the germinal centers and become plasma cells.31 Therefore, the fact that many IgG4-producing plasma cells were found selectively in the germinal centers of our patients was a unique feature. The mechanisms involved in this feature are not clear. Zen et al10 have reported that the expressions of T helper (Th) 2 cytokines (interleukin-4, interleukin-5, and interleukin-13) and regulatory cytokines (interleukin-10 and transforming growth factor-β) were upregulated in the affected tissues of patients with IgG4-related sclerosing pancreatitis and cholangitis. They have suggested that the prominent Th2 and regulatory immune reactions in this disease might indicate that its pathogenesis involves an allergic mechanism. In addition, they described that interleukin-10 has a major role in directing B-cells to produce IgG4.10 Therefore, interleukin-10 might induce differentiation of B cells into IgG4-positive plasma cells in the germinal centers. At any rate, this unique histological feature could be a special finding for IgG4-related lymphadenopathy.
Interestingly, eight of our nine cases (89%) of systemic IgG4-related lymphadenopathy showed eosinophil infiltration. Zen et al10 reported that eosinophils infiltrated in the affected tissues in their patients with IgG4-related sclerosing pancreatitis and cholangitis. As previously mentioned, Th2 cytokines (interleukin-4, interleukin-5, and interleukin-13) were upregulated in the affected tissues of patients with IgG4-related disease. Interleukin-5 and interleukin-13 were activated by eosinophil infiltration and IgE production. Masaki et al6 have reported that serum IgE level is elevated in IgG4-related diseases. In our series, the serum IgE value was significantly elevated in the examined patients. So, the findings of eosinophilic infiltration and serum IgE value elevation might be a specific finding of IgG4-related disease.
Little is known about the lymphomagenesis of IgG4-related disease. We recently reported the first case of marginal zone B-cell lymphoma arising from ocular adnexal IgG4-related disease7 and IgG4-producing marginal zone B-cell lymphoma.32 However, the present series showed no immunoglobulin light-chain restriction and no immunoglobulin heavy chain gene rearrangement.
In conclusion, in systemic IgG4-related disease, C-reactive protein and interleukin-6 are usually not elevated. Systemic IgG4-related disease and multicentric Castleman's disease showed overlapping but somewhat distinct pathologic findings, and serum data (especially C-reactive protein and interleukin-6) are useful to differentiate between them. Eosinophilic infiltration and serum IgE value elevation might be a specific feature of IgG4-related lymphadenopathy.
References
Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732–738.
Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002;359:1403–1404.
Kamisawa T, Okamoto A . IgG4-related sclerosing disease. World J Gastroenterol 2008;14:3948–3955.
Kamisawa T, Nakajima H, Egawa N, et al. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 2006;6:132–137.
Kojima M, Miyawaki S, Takada S, et al. Lymphoplasmacytic infiltrate of regional lymph nodes in Küttner's tumor (chronic sclerosing sialadenitis): a report of 3 cases. Int J Surg Pathol 2008;16:263–268.
Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multi-organ lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 2008 published online 13 Aug 2008; doi: 10.1136/ard.2008.089169.
Sato Y, Ohshima K, Ichimura K, et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int 2008;58:465–470.
Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007;20:23–28.
Zen Y, Fujii T, Sato Y, et al. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol 2007;20:884–894.
Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007;45:1538–1546.
Cheuk W, Yuen HKL, Chu SYY, et al. Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol 2008;32:671–681.
Castleman B, Iverson L, Menendez VP . Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer 1956;9:822–830.
Flendrig JA, Schillings PHM . Benign giant lymphoma: the clinical signs and symptoms. Folia Med Neerl 1969;12:119–120.
Keller AR, Hochholzer L, Castleman B . Hyalinevascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670–683.
Frizzera G, Peterson BA, Bayrd ED, et al. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 1985;3:1202–1216.
Nishimoto N, Kanakura Y, Aozasa K, et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman's disease. Blood 2005;106:2627–2632.
Kojima M, Nakamura S, Shimizu K, et al. Clinical implication of idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia: a report of 16 cases. Int J Surg Pathol 2004;12:25–30.
Kojima M, Nakamura N, Tsukamoto N, et al. Clinical implication of multicentric Castleman's disease among Japanese: a report of 28 cases. Int J Surg Pathol 2008;16:391–398.
Mannami T, Yoshino T, Oshima K, et al. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia. Mod Pathol 2001;14:641–649.
Sato Y, Nakamura N, Nakamura S, et al. Deviated VH4 immunoglobulin gene usage is found among thyroid mucosa-associated lymphoid tissue lymphomas, similar to the usage at other sites, but is not found in thyroid diffuse large B-cell lymphomas. Mod Pathol 2006;19:1578–1584.
Sato Y, Ichimura K, Tanaka T, et al. Duodenal follicular lymphomas share common characteristics with mucosa-associated lymphoid tissue lymphomas. J Clin Pathol 2008;61:377–381.
Dongen JV, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 action BMH4-CT98-3936. Leukemia 2003;17:2257–2317.
Koo CH, Nathwani BN, Winberg CD, et al. Atypical lymphoplasmacytic and immunoblastic proliferation in lymph nodes of patients with autoimmune disease (autoimmune-disease-associated lymphadenopathy). Medicine (Baltimore) 1984;64:274–290.
Kojima M, Motoori T, Hosomura Y, et al. Atypical lymphoplasmacytic and immunoblastic proliferation from rheumatoid arthritis: a case report. Pathol Res Prac 2006;202:51–54.
Usón J, Balsa A, Pascual-Salcedo D . Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies. J Rheumatol 1997;24:2069–2075.
Nishimoto N, Terao K, Mima T, et al. Mechanisms and pathological significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman's disease. Blood 2008;112:3959–3964.
Castell JV, Gómez-Lechón MJ, David M, et al. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 1988;232:347–350.
Castell JV, Gómez-Lechón MJ, David M, et al. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990;12:1179–1186.
Gabay C, Kushner I . Acute-phase proteins and other systemic responses to inflammation. N Eng J Med 1999;340:448–454.
Yokoyama A . Interleukin-6 (IL-6) / soluble IL-6 receptor. Nippon Rinsho 2005;63:72–74.
Kondo E, Nakamura S, Onoue H, et al. Detection of bcl-2 protein and bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization. Blood 1992;80:2044–2051.
Sato Y, Takata K, Ichimura K, et al. IgG4-producing marginal zone B-cell lymphoma. Int J Hematol 2008;88:428–433.
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclosure/conflict of interest
The authors have no potential conflicts of interest.
Rights and permissions
About this article
Cite this article
Sato, Y., Kojima, M., Takata, K. et al. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Mod Pathol 22, 589–599 (2009). https://doi.org/10.1038/modpathol.2009.17
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/modpathol.2009.17
Keywords
This article is cited by
-
An overlapping case of IgG4-related disease and systemic lupus erythematosus treated with belimumab: a case-based review
Rheumatology International (2024)
-
Reaktive Lymphadenopathien
Wiener klinisches Magazin (2023)
-
Reaktive Lymphadenopathien
Die Pathologie (2022)
-
Utility of renal biopsy in differentiating idiopathic multicentric Castleman disease from IgG4-related disease
CEN Case Reports (2022)
-
T-lymphoblastic leukemia/lymphoma with interfollicular growth pattern and Castleman-like morphologic features
Journal of Hematopathology (2021)